| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0087 | 0.9 |